AstraZeneca Plc AZN released topline data from the Phase 3 program for efzimfotase alfa (ALXN1850) in the broad ...

Friday's positive trial results for tozorakimab mark a significant inflexion point for AstraZeneca PLC (LSE:AZN, NASDAQ:AZN), ...

AstraZeneca has delivered a solid trailing 12 months, with shares up 31.43% over the past year, but the stock has pulled back nearly 5% over the past month.

On Friday, AstraZeneca Plc AZN released positive topline data from Phase 3 OBERON and TITANIA trials of tozorakimab in ...

The Centers for Medicare & Medicaid Services is asking a federal court to dismiss AstraZeneca Plc’s challenge against a government drug price negotiation program, arguing a Biden-era law bars judicial ...

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) shares rose 3% to 14,230p, placing the drugmaker at the top of the FTSE 100 leaderboard ...

AstraZeneca PLC (NYSE:AZN) is one of the 12 Best UK Stocks to Buy According to Hedge Funds. On March 16, 2026, AstraZeneca ...

AstraZeneca shares jump sharply amid strong premarket trading; Institutional activity reflects growing interest across healthcare sector; Biopharma pipeline continues ...

AstraZeneca PLC on Tuesday said phase-three testing of its replacement efzimfotase alfa enzyme on patients affected by hypophosphatasia yielded positive safety and efficacy results. Shares in ...

AstraZeneca PLC (NASDAQ:AZN) is one of the most profitable blue chip stocks to invest in now. Guggenheim lifted the price ...

AstraZeneca PLC closed 9.09% below its 52-week high of £157.32, which the company reached on February 18th.

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...